Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Susie Lisa — Vice President, Investor Relations
Michael F. Mahoney — Chairman and Chief Executive Officer
Daniel J. Brennan — Executive Vice President and Chief Financial Officer
Kenneth Stein — Senior Vice President and Chief Medical Officer, CRM
Analysts:
Robert A. Hopkins — Bank of America Merrill Lynch — Analyst
David Ryan Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo Securities — Analyst
Joanne Wuensch — Citi — Analyst
Robert Marcus — J.P. Morgan — Analyst
Matthew Taylor — UBS — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,